Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathan Ford

Showing results (171-180 of 458) with videos related to

Pageof 46
Sort By:
Conflict and Health|March 26, 2009
Mortality, violence and access to care in two districts of Port-au-Prince, HaitiFrédérique Ponsar, Nathan Ford, Michel Van Herp, et al.
Conflict and Health|July 11, 2018
Provision and continuation of antiretroviral therapy during acute conflict: the experience of MSF in Central African Republic and YemenCecilia Ferreyra, Daniel O'Brien, Beatriz Alonso, et al.
AIDS (London, England)|December 19, 2009
Ensuring sustainable antiretroviral provision during economic crisesEdward J Mills, Nathan Ford, Christine Nabiryo, et al.
AIDS (London, England)|February 9, 2012
Treatment outcomes of patients on second-line antiretroviral therapy in resource-limited settings: a systematic review and meta-analysisOlawale Ajose, Siddharth Mookerjee, Edward J Mills, et al.
Southern African Journal of HIV Medicine|January 21, 2020
Loss to follow-up from antiretroviral therapy clinics: A systematic review and meta-analysis of published studies in South Africa from 2011 to 2015Samantha Kaplan, Katleho S Nteso, Nathan Ford, et al.
Lancet (London, England)|August 31, 2010
Extensively drug-resistant tuberculosis in South AfricaHelen Cox, Nathan Ford, Cheryl McDermid, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 15, 2015
Choice of antiretroviral drugs for postexposure prophylaxis for children: a systematic reviewMartina Penazzato, Ken Dominguez, Mark Cotton, et al.
Lancet (London, England)|May 28, 2003
25 years of the WHO essential medicines lists: progress and challengesRichard Laing, Brenda Waning, Andy Gray, et al.
Drug Discovery Today|July 5, 2008
How developing world concerns need to be part of drug development plans: a case study of four emerging antiretroviralsJens van Roey, Tido von Schoen-Angerer, Nathan Ford, et al.
Conflict and Health|January 8, 2009
Universal access: the benefits and challenges in bringing integrated HIV care to isolated and conflict affected populations in the Republic of CongoDaniel P O'Brien, Clair Mills, Catherine Hamel, et al.
Pageof 46

Showing results (171-180 of 458) with videos related to

Sort By:
Pageof 46
Conflict and Health|March 26, 2009
Mortality, violence and access to care in two districts of Port-au-Prince, HaitiFrédérique Ponsar, Nathan Ford, Michel Van Herp, et al.
Conflict and Health|July 11, 2018
Provision and continuation of antiretroviral therapy during acute conflict: the experience of MSF in Central African Republic and YemenCecilia Ferreyra, Daniel O'Brien, Beatriz Alonso, et al.
AIDS (London, England)|December 19, 2009
Ensuring sustainable antiretroviral provision during economic crisesEdward J Mills, Nathan Ford, Christine Nabiryo, et al.
AIDS (London, England)|February 9, 2012
Treatment outcomes of patients on second-line antiretroviral therapy in resource-limited settings: a systematic review and meta-analysisOlawale Ajose, Siddharth Mookerjee, Edward J Mills, et al.
Southern African Journal of HIV Medicine|January 21, 2020
Loss to follow-up from antiretroviral therapy clinics: A systematic review and meta-analysis of published studies in South Africa from 2011 to 2015Samantha Kaplan, Katleho S Nteso, Nathan Ford, et al.
Lancet (London, England)|August 31, 2010
Extensively drug-resistant tuberculosis in South AfricaHelen Cox, Nathan Ford, Cheryl McDermid, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 15, 2015
Choice of antiretroviral drugs for postexposure prophylaxis for children: a systematic reviewMartina Penazzato, Ken Dominguez, Mark Cotton, et al.
Lancet (London, England)|May 28, 2003
25 years of the WHO essential medicines lists: progress and challengesRichard Laing, Brenda Waning, Andy Gray, et al.
Drug Discovery Today|July 5, 2008
How developing world concerns need to be part of drug development plans: a case study of four emerging antiretroviralsJens van Roey, Tido von Schoen-Angerer, Nathan Ford, et al.
Conflict and Health|January 8, 2009
Universal access: the benefits and challenges in bringing integrated HIV care to isolated and conflict affected populations in the Republic of CongoDaniel P O'Brien, Clair Mills, Catherine Hamel, et al.
Pageof 46